IF007
Interferon-α A Protein, Recombinant human
Purified Recombinant Human Interferon Alpha A (Hu-IFN-alphaA & Hu-IFN-alpha2a).
Synonym(s):
Interferon alpha-2
Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| ≥5000000 units | Estimated to ship TODAY | $462.00 |
About This Item
UNSPSC Code:
12352202
NACRES:
NA.75
eCl@ss:
32160405
Form:
liquid
Assay:
95%
Biological source:
human
Recombinant:
expressed in E. coli
$462.00
Estimated to ship TODAYDetails
biological source
human
Quality Level
recombinant
expressed in E. coli
assay
95%
form
liquid
manufacturer/tradename
Chemicon®
technique(s)
cell culture | mammalian: suitable
NCBI accession no.
UniProt accession no.
shipped in
dry ice
storage temp.
-65 to -96°C
General description
Product Source: cDNA obtained from human leukocyte mRNA expressed in E. coli.
Purified Recombinant Human Interferon Alpha A (Hu-IFN-alphaA; Hu-IFN-alpha2a). Human Gene: IFNA2
Physical form
Frozen, in PBS containing 0.1% bovine serum albumin (BSA).
Preparation Note
After receipt, this product should be kept at -70°C or below for retention of full activity. When thawing, the contents of the tube should be apportioned in separate tubes so that freezing and thawing is kept to a minimum. Dilute only in buffers containing protein such as 0.1% bovine serum albumin (BSA).
Analysis Note
Specific Activity: Determined by assaying inhibition of virus-induced cytopathic effect.In this antiviral assay for interferon, about 1 unit/ml of interferon is the quantity necessary to produce a cytopathic effect of 50%
Other Notes
Specific Activity: The units are determined with respect to the international reference standard for human interferon alpha A (Hu-IFN-alphaA) provided by the National Institutes of Health.Unit of activity measured on bovine MDBK cells challenged with vesicular stomatitis virus (VSV).
Legal Information
CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany
Disclaimer
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
1 of 1
This Item | |||
|---|---|---|---|
| biological source human | biological source mouse | biological source human | biological source human |
| assay 95% | assay >95% | assay ≥95% | assay ≥95% |
| technique(s) cell culture | mammalian: suitable | technique(s) cell culture | mammalian: suitable | technique(s) cell culture | mammalian: suitable | technique(s) cell culture | mammalian: suitable |
| recombinant expressed in E. coli | recombinant expressed in E. coli | recombinant expressed in E. coli | recombinant expressed in E. coli |
| form liquid | form liquid | form buffered aqueous solution | form buffered aqueous solution |
| UniProt accession no. | UniProt accession no. | UniProt accession no. | UniProt accession no. |
Storage Class
12 - Non Combustible Liquids
wgk
WGK 2
Certificates of Analysis (COA)
Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Related Content
Induction of PARP7 Creates a Vulnerability for Growth Inhibition by RBN2397 in Prostate Cancer Cells.
Yang, et al.
Cancer research communications, 3, 592-606 (2023)
Ming-Wei Jan et al.
Viruses, 14(7) (2022-07-28)
Human platelet lysate (hPL) contains abundant growth factors for inducing human cell proliferation and may be a suitable alternative to fetal bovine serum (FBS) as a culture medium supplement. However, the application of hPL in virological research remains blank. Parechovirus
Yang Liu et al.
Nature communications, 13(1), 4337-4337 (2022-07-28)
We report a live-attenuated SARS-CoV-2 vaccine candidate with (i) re-engineered viral transcription regulator sequences and (ii) deleted open-reading-frames (ORF) 3, 6, 7, and 8 (∆3678). The ∆3678 virus replicates about 7,500-fold lower than wild-type SARS-CoV-2 on primary human airway cultures
Global Trade Item Number
| SKU | GTIN |
|---|---|
| IF007 | 04053252372438 |